Literature DB >> 21884984

Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis.

Bushra Raj1, Dave O'Hanlon, John P Vessey, Qun Pan, Debashish Ray, Noel J Buckley, Freda D Miller, Benjamin J Blencowe.   

Abstract

Neurogenesis requires the concerted action of numerous genes that are regulated at multiple levels. However, how different layers of gene regulation are coordinated to promote neurogenesis is not well understood. We show that the neural-specific Ser/Arg repeat-related protein of 100 kDa (nSR100/SRRM4) negatively regulates REST (NRSF), a transcriptional repressor of genes required for neurogenesis. nSR100 directly promotes alternative splicing of REST transcripts to produce a REST isoform (REST4) with greatly reduced repressive activity, thereby activating expression of REST targets in neural cells. Conversely, REST directly represses nSR100 in nonneural cells to prevent the activation of neural-specific splicing events. Consistent with a critical role for nSR100 in the inhibition of REST activity, blocking nSR100 expression in the developing mouse brain impairs neurogenesis. Our results thus reveal a fundamental role for direct regulatory interactions between a splicing activator and transcription repressor in the control of the multilayered regulatory programs required for neurogenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21884984     DOI: 10.1016/j.molcel.2011.08.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  67 in total

1.  Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.

Authors:  Mark P Labrecque; Ilsa M Coleman; Lisha G Brown; Lawrence D True; Lori Kollath; Bryce Lakely; Holly M Nguyen; Yu C Yang; Rui M Gil da Costa; Arja Kaipainen; Roger Coleman; Celestia S Higano; Evan Y Yu; Heather H Cheng; Elahe A Mostaghel; Bruce Montgomery; Michael T Schweizer; Andrew C Hsieh; Daniel W Lin; Eva Corey; Peter S Nelson; Colm Morrissey
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

2.  Tryptophan hydroxylase-2: an emerging therapeutic target for stress disorders.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Biochem Pharmacol       Date:  2013-02-19       Impact factor: 5.858

Review 3.  Neurogenesis during development of the vertebrate central nervous system.

Authors:  Judith T M L Paridaen; Wieland B Huttner
Journal:  EMBO Rep       Date:  2014-03-17       Impact factor: 8.807

4.  Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.

Authors:  Roberto Ferrarese; Griffith R Harsh; Ajay K Yadav; Eva Bug; Daniel Maticzka; Wilfried Reichardt; Stephen M Dombrowski; Tyler E Miller; Anie P Masilamani; Fangping Dai; Hyunsoo Kim; Michael Hadler; Denise M Scholtens; Irene L Y Yu; Jürgen Beck; Vinodh Srinivasasainagendra; Fabrizio Costa; Nicoleta Baxan; Dietmar Pfeifer; Dominik von Elverfeldt; Rolf Backofen; Astrid Weyerbrock; Christine W Duarte; Xiaolin He; Marco Prinz; James P Chandler; Hannes Vogel; Arnab Chakravarti; Jeremy N Rich; Maria S Carro; Markus Bredel
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

Review 5.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

6.  Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions.

Authors:  Eduardo Javier Lopez Soto; Michael J Gandal; Thomas Gonatopoulos-Pournatzis; Elizabeth A Heller; Diou Luo; Sika Zheng
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

7.  Rest represses maturation within migrating facial branchiomotor neurons.

Authors:  Crystal E Love; Victoria E Prince
Journal:  Dev Biol       Date:  2015-03-11       Impact factor: 3.582

8.  Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.

Authors:  Xiaochang Zhang; Ming Hui Chen; Xuebing Wu; Andrew Kodani; Jean Fan; Ryan Doan; Manabu Ozawa; Jacqueline Ma; Nobuaki Yoshida; Jeremy F Reiter; Douglas L Black; Peter V Kharchenko; Phillip A Sharp; Christopher A Walsh
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

9.  Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits.

Authors:  Yuanchao Xue; Kunfu Ouyang; Jie Huang; Yu Zhou; Hong Ouyang; Hairi Li; Gang Wang; Qijia Wu; Chaoliang Wei; Yanzhen Bi; Li Jiang; Zhiqiang Cai; Hui Sun; Kang Zhang; Yi Zhang; Ju Chen; Xiang-Dong Fu
Journal:  Cell       Date:  2013-01-11       Impact factor: 41.582

Review 10.  Brain REST/NRSF Is Not Only a Silent Repressor but Also an Active Protector.

Authors:  Yangang Zhao; Min Zhu; Yanlan Yu; Linli Qiu; Yuanyuan Zhang; Li He; Jiqiang Zhang
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.